Biolase Technology, Inc. (BLTI) Posts Second Consecutive Breakeven Quarter, Raises Q2 Revenue Guidance
Tweet Send to a Friend
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q1 EPS of $0.00, $0.02 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
